• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOMET FRANCE S.A.R.L. FEMORAL STEM AURA II HA / SIZE 6 RIGHT / CEMENTLESS / 542 / 12-14; PROTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOMET FRANCE S.A.R.L. FEMORAL STEM AURA II HA / SIZE 6 RIGHT / CEMENTLESS / 542 / 12-14; PROTHESIS, HIP Back to Search Results
Catalog Number P0126H06
Device Problem Insufficient Information (3190)
Patient Problem Hip Fracture (2349)
Event Date 03/08/2007
Event Type  Injury  
Manufacturer Narrative
(b)(4).Foreign report source: (b)(6).The investigation is in progress.Once the investigation has been completed, a follow-up mdr will be submitted.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.
 
Event Description
It has been reported over the data from (b)(6) : review the performance of implants following a review of the data conducted in march 2019 on aura ii, on 304 primaries surgeries, 33 have been revised during the first year postoperative.This complaint is related to revision due to periprosthetic fracture: it was reported that a patient underwent revision (hip, right) due to periprosthetic fracture, 2 days after implantation.The stem and the head were removed.
 
Manufacturer Narrative
(b)(4).This follow-up report is being submitted to relay additional information.No other information provided (x-ray, surgical report, photographs, lab test).Therefore, the reported event could not be confirmed.The device was not returned to the manufacturer.Therefore it could not be analyzed.The device manufacturing quality record could not been reviewed as the item number and the lot number were not communicated.Within 3 years, 3 complaints (involving 6 products) have been recorded on optipac refobacin bone cement r regarding revision.According to available data, root cause of the event was unable to be determined.However, there is no evidence that the event is related to the product.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Event Description
It has been reported over the data from njr (national joint registry - uk) : review the performance of implants following a review of the data conducted in (b)(6) 2019 on aura ii, on 304 primaries surgeries, 33 have been revised during the first year postoperative.This complaint is related to revision due to periprosthetic fracture: it was reported that a patient underwent revision (hip, right) due to periprosthetic fracture, 2 days after implantation.The stem and the head were removed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FEMORAL STEM AURA II HA / SIZE 6 RIGHT / CEMENTLESS / 542 / 12-14
Type of Device
PROTHESIS, HIP
Manufacturer (Section D)
BIOMET FRANCE S.A.R.L.
plateau de lautagne bp75
valence cedex 26903
FR  26903
MDR Report Key10008614
MDR Text Key194059383
Report Number3006946279-2020-00081
Device Sequence Number1
Product Code JDI
UDI-Device Identifier03599870002988
UDI-Public3599870002988
Combination Product (y/n)N
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,study
Type of Report Initial,Followup
Report Date 09/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date11/30/2010
Device Catalogue NumberP0126H06
Device Lot Number0000171105
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/07/2020
Initial Date FDA Received04/29/2020
Supplement Dates Manufacturer Received09/15/2020
Supplement Dates FDA Received09/16/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
ASSOCIATED DEVICES LISTED IN H10.
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age53 YR
-
-